Free Trial

CenterBook Partners LP Makes New Investment in Arteris, Inc. $AIP

Arteris logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • CenterBook Partners initiated a position in Arteris, buying 195,954 shares worth approximately $4.63 million, or about 0.40% of the company.
  • Arteris reported Q3 revenue of $25.8 million, above estimates, and a smaller-than-expected loss of $0.02 per share. It forecast FY2026 revenue of $98.5 million to $99.5 million, though the company remains unprofitable.
  • Analysts have a consensus “Moderate Buy” rating and an average price target of $35.86; six analysts rate the stock Buy and one rates it Sell.
  • MarketBeat previews top five stocks to own in December.

CenterBook Partners LP acquired a new position in Arteris, Inc. (NASDAQ:AIP - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 195,954 shares of the company's stock, valued at approximately $4,632,000. CenterBook Partners LP owned about 0.40% of Arteris at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of AIP. Versant Capital Management Inc increased its position in shares of Arteris by 33.7% during the 2nd quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock valued at $56,000 after purchasing an additional 290 shares during the last quarter. Farther Finance Advisors LLC raised its stake in shares of Arteris by 106.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,730 shares of the company's stock worth $41,000 after purchasing an additional 890 shares during the period. Sterling Capital Management LLC raised its stake in shares of Arteris by 612.5% during the 3rd quarter. Sterling Capital Management LLC now owns 1,197 shares of the company's stock worth $28,000 after purchasing an additional 1,029 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of Arteris in the 2nd quarter worth about $53,000. Finally, Nisa Investment Advisors LLC boosted its holdings in shares of Arteris by 55.9% in the 3rd quarter. Nisa Investment Advisors LLC now owns 4,714 shares of the company's stock worth $111,000 after buying an additional 1,690 shares during the last quarter. Hedge funds and other institutional investors own 64.36% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on AIP. Roth Capital assumed coverage on shares of Arteris in a research report on Tuesday, August 4th. They set a "buy" rating and a $40.00 price target for the company. Weiss Ratings raised shares of Arteris from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday, August 21st. Rosenblatt Securities reiterated a "buy" rating and issued a $38.00 target price on shares of Arteris in a research note on Friday, August 7th. TD Cowen reduced their target price on shares of Arteris from $40.00 to $25.00 and set a "buy" rating for the company in a research report on Monday, October 19th. Finally, Jefferies Financial Group decreased their price target on shares of Arteris from $50.00 to $40.00 and set a "buy" rating for the company in a research note on Friday. Six investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Arteris currently has a consensus rating of "Moderate Buy" and an average price target of $35.86.

Get Our Latest Stock Report on AIP

Arteris News Summary

Here are the key news stories impacting Arteris this week:

  • Positive Sentiment: Arteris reported Q3 revenue of $25.8 million, above the roughly $24.6 million consensus estimate. Its loss of $0.02 per share was narrower than analysts expected and improved from a $0.09 loss a year earlier. Arteris Q3 results and guidance
  • Positive Sentiment: The company forecast Q4 revenue of $25.7 million to $26.7 million and FY2026 revenue of $98.5 million to $99.5 million. It also set a $103 million to $107 million target for annual contract value plus royalties, offering investors visibility into expected business activity. Arteris FY2026 forecast
  • Positive Sentiment: Arteris surpassed 1,000 customer chip-design starts. The company says AI accounted for about half of its recent projects, pointing to potential demand from a fast-growing market. Arteris surpasses 1,000 customer design starts
  • Negative Sentiment: Despite the improvement and estimate beat, Arteris remains loss-making, so investors may continue to watch its path toward profitability. Arteris Q3 loss and revenue results

Insider Buying and Selling at Arteris

In other Arteris news, major shareholder Bayview Legacy, Llc sold 100,000 shares of the stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $23.82, for a total transaction of $2,382,000.00. Following the completion of the transaction, the insider owned 8,129,071 shares in the company, valued at $193,634,471.22. This trade represents a 1.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Paul Alpern sold 6,003 shares of Arteris stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $24.24, for a total transaction of $145,512.72. Following the completion of the transaction, the vice president owned 61,082 shares of the company's stock, valued at $1,480,627.68. The trade was a 8.95% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 478,631 shares of company stock valued at $10,823,565 in the last three months. 23.30% of the stock is owned by company insiders.

Arteris Stock Up 11.7%

Shares of NASDAQ AIP opened at $17.80 on Friday. Arteris, Inc. has a one year low of $12.06 and a one year high of $50.26. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.57 and a quick ratio of 1.57. The business's fifty day moving average price is $21.39 and its 200-day moving average price is $24.94. The stock has a market capitalization of $874.87 million, a PE ratio of -20.00 and a beta of 1.93.

Arteris (NASDAQ:AIP - Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.02. Arteris had a negative return on equity of 184.29% and a negative net margin of 44.83%. The company had revenue of $25.77 million during the quarter, compared to the consensus estimate of $24.57 million. On average, equities research analysts anticipate that Arteris, Inc. will post -0.68 EPS for the current year.

About Arteris

(Free Report)

Arteris, Inc is a semiconductor intellectual property (IP) company that provides technology used to design and integrate complex systems-on-chip (SoCs). Its products help semiconductor and system developers connect, manage and verify the various processing, memory and specialized functional components incorporated into modern chips.

The company's portfolio includes network-on-chip (NoC) interconnect and semiconductor IP solutions, including its FlexNoC interconnect technology, Ncore cache-coherent interconnect IP and CodaCache products.

Featured Articles

Institutional Ownership by Quarter for Arteris (NASDAQ:AIP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines